HighTide Therapeutics, Inc. (2511.HK)
HighTide Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and liver diseases in Mainland China.
2.60+0.04%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-15.6%
The outlook
HighTide Therapeutics, Inc. currently reads as bearish based on below its 50- & 200-day averages, 27% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range27% of the way from its 52-week low to high
Market cap
$1.32B
52-wk high
4.72
52-wk low
1.80
50-day avg
2.86
200-day avg
3.04
Trailing P/E
—